Stay updated on SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Sign up to get notified when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.

Latest updates to the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.5.2 to v3.5.3, indicating a newer version of the page documentation. No substantive study content appears to be altered.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAlbert Einstein College of Medicine was removed from the Collaborators and Investigators section; the record shows updates including Revision: v3.5.2 and new entries dated 2026-04-07 and 2026-04-09.SummaryDifference0.6%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedPage metadata updated to Revision: v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded new collaborators/institutions (Henry Ford Cancer Institute, New York University, University of Michigan) and Merck Sharp & Dohme LLC to the study record. Included a link to the SPRINT publication in The Journal of Clinical Oncology and introduced a Study Results section with revision v3.4.3.SummaryDifference0.7%

- Check84 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior government funding/operating status notice (v3.4.1). These changes are site-wide maintenance updates and do not affect the study details on the page.SummaryDifference0.4%

- Check91 days agoChange DetectedA government funding notice was added to inform users about potential disruptions and where to check status updates. The site revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.